QSM Diagnostics, Mella Pet Care integrate platforms for infection testing

Mella Pet Care, an ecosystem of health monitoring solutions for veterinarians and pet parents, announced its integration with QSM Diagnostics, a medical device company that develops instruments and test kits for bacterial identification, resulting in faster recovery with targeted treatment. This collaboration will allow users to employ a singular platform to ease the adoption of new technologies into veterinary clinics, according to a news release.

All users of the Mella Desktop Application will now be able to operate the QSM Otter eQ instrument out of the box on their pre-existing platform, removing the necessity to run separate software. The Mella application will guide users through the testing process to prevent errors. QSM users will automatically receive test results and store reports in their Patient Management System.

Mella, whose Mella Pro Smart Underarm Thermometers are in approximately 1,000 veterinary clinics worldwide, and QSM Diagnostics, are also unveiling the addition of the QSM OTTER eQ instrument platform into the Mella Desktop Application. This test is improving antibiotic stewardship for veterinarians by increasing the accuracy of identifying bacterial infections.

“Veterinarians are busy and many we’ve spoken with don’t have the time to learn new technology”, said Anya Babbitt, co-founder and CEO of Mella Pet Care, in the news release. “Streamlining one platform benefits both startups and veterinary professionals. Now, we’ve created the ability to send infection test results directly back into the patient record.”   Dr. Alex Schechter, DVM and founder of Burrwood Veterinary in Birmingham Michigan, said that currently, veterinarians cannot identify the bacterial species present in a sample, leading to incorrectly prescribed antibiotics up to 25% of the time.

With QSM’s faster bacterial detection and identification, veterinarians can prescribe targeted antibiotics for their patients.   For more information, visit and Mella will be offering QSM products, as part of the strategic partnership, at

About Mella Pet Care

Mella Pet Care, a Chicago-based startup, is building the future of pet care with an ecosystem of health monitoring solutions for veterinarians and pet parents, including the first-ever accurate axillary thermometer, a body fat analyzer, a chip reader, pulse ox and more. Preventative tools are now accessible, allowing pets to live longer, happier lives. Mella has won 14 industry awards including the 2021 Purina Pet Care Innovation Prize and Mars’ 2022 Leap Venture Studio accelerator.

About QSM Diagnostics

Boston, Massachusetts-based QSM Diagnostics is fundamentally changing how infections are diagnosed and treated. The company’s patented technology allows veterinarians to provide better treatment for their patients and helps mitigate the spread of antimicrobial resistance by making testing faster and easier. QSM’s products also increase pet owners’ engagement and improve drug administration compliance by educating and involving owners in their pet’s health. QSM diagnostics won multiple animal health industry awards, including the 2021 Animal Health Innovation Award and the 2022 Purina Pet Care Innovation Prize.

  • Please enter a comment

Name *
Email address *
Comment *

* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.

I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies

More news

Zoetis is Redefining the Feline Veterinary Experience with the Commercial Launch of Bonqat® (pregabalin oral solution) in the U.S.


Spatio-temporal patterns of tick-borne disease diagnoses in Indiana, USA (2009–2018)


Abdominal ultrasonographic findings of cats with feline infectious peritonitis: an update


Pseudohyperkalemia in horses with rhabdomyolysis reported by an enzymatic chemistry analyzer


Retrospective evaluation of prognosis and survival with various immunosuppressants in 82 dogs diagnosed with meningoencephalitis of unknown etiology (2010-2021).




News of interest


Copyright © 2024 - All Rights Reserved
ISSN 2768-198X